Pricing Log in Create free account

IN8bio, Inc. (INAB) vs Phio Pharmaceuticals Corp. (PHIO)

IN8bio, Inc. and Phio Pharmaceuticals Corp. are both Biotechnology companies. Phio Pharmaceuticals Corp. is the larger, with a market value of $9.3M against $8.2M — 1.1× the size. Across the 10 metrics below, IN8bio, Inc. leads on 5 and Phio Pharmaceuticals Corp. on 5.

Valuation

Metric INAB PHIO Biotechnology median
P/E n/m n/m 10.26
P/S n/m 68.34 9.18
P/B 0.89 0.74 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.08 0.26 0.65
EV/Sales n/m (25.52) 8.98
Earnings yield (255.95%) (174.15%) (34.89%)
Free cash flow yield (89.47%) (131.34%) (24.52%)

Profitability

Metric INAB PHIO Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (111.11%) (113.71%) (50.12%)
Return on assets (90.80%) (100.78%) (45.60%)
Return on invested capital (2,948.56%) 0.00% 0.00%

Growth

Metric INAB PHIO Biotechnology median
Revenue growth (TTM) — 78.95% 6.26%
EPS growth (last fiscal year) 74.06% 84.03% 29.88%
Revenue growth, 5-year CAGR — (21.62%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INAB PHIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.21 8.39 4.89
Net debt to EBITDA 1.56 2.28 1.01

Dividend

Metric INAB PHIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INAB PHIO Biotechnology median
Market cap 8.19m 9.30m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack